About IonGate Biosciences GmbH
IonGate Biosciences develops, produces and markets innovative screening technologies to investigate electrically active transporters, and is the worldwide leader in this new area.
Innovative solutions
Transporters are essential for the metabolic functions of the cell, information processing in the entire organism, and play a fundamental role in the health of humans. Due to their difficult experimental accessibility, transporters are underrepresented in current drug screening processes. IonGate has developed a range of instrumentation based on its proprietary SURFE²R™ technology to enable highly precise functional screening of transporters in the higher-throughput pharmaceutical discovery and development environments. IonGate provides total system solutions, encompassing disposables and reagents, consulting services which include the design of assays and customized applications, and contract laboratory services.
On solid ground
IonGate Biosciences GmbH is a growing, venture-capital financed, biotechnology enterprise located in Frankfurt/Main, Germany. In addition to the main financier and leading partner Heidelberg Innovation, the KfW holds a stake in IonGate. The company was founded in 2000 by a team of scientists from the biotechnological and pharmaceutical industry and the Max-Planck-Institute of Biophysics (MPI of Biophysics) in Frankfurt.
